Showing results (121-130 of 246) with videos related to
Sort By:
Pageof 25
Clinical Genetics|June 1, 1996
Interstitial 6q deletion and Prader-Willi-like phenotypeC K Stein, S E Stred, L L Thomson, et al.Acta Cytologica|March 1, 1992
Aspiration biopsy smear pattern as a predictor of biologic behavior in adenocarcinoma of the breastL J Layfield, M E Robert, H Cramer, et al.Peptides|January 1, 1990
Cerebrospinal fluid levels of immunoreactive substance P and somatostatin in patients with multiple sclerosis and inflammatory CNS diseaseN Rösler, C Reuner, J Geiger, et al.Bioconjugate Chemistry|February 14, 1998
Methods for the characterization of phosphatase-stabilized 2-5A-antisense chimerasM R Player, W Xiao, H Cramer, et al.Der Nervenarzt|May 31, 2018
[Herbal medicines for psychiatric disorders]D Anheyer, H Haller, P Klose, et al.Neuropeptides|April 1, 1990
Ventricular fluid neuropeptides in Parkinson's disease. I. Levels and distribution of somatostatin-like immunoreactivityS Jost, C Reuner, M Mohadjer, et al.Journal of the American Geriatrics Society|January 1, 1990
Somatostatin-like immunoreactivity in the cerebrospinal fluid of aged patients with Parkinson's disease. The effect of dopatherapyH Masson, I Popescu, D Strubel, et al.Journal of Neurology|January 1, 1985
Ventricular somatostatin-like immunoreactivity in patients with basal ganglia diseaseH Cramer, A Wolf, K Rissler, et al.Regulatory Peptides|January 1, 1986
Permeability of epidural somatostatin and morphine into the intrathecal space of dogsJ Chrubasik, K Bonath, H Cramer, et al.European Journal of Cancer Care|July 10, 2013
A systematic review and meta-analysis of exercise interventions for colorectal cancer patientsH Cramer, R Lauche, P Klose, et al.Pageof 25